Radioimmunotherapy with 90Y-Zevalin in mantle cell lymphoma patients.

被引：0
|
作者：
Sowa-Staszczak, A.
Hubalewska-Dydejczyk, A.
Jurczak, W.
Huszno, B.
Giza, A.
Wegrzyn, J.
Skotnicki, A.
机构：
[1] Jagiellonian Univ, Dept Endocrinol, Coll Med, Nucl Med Unit, Krakow, Poland
[2] Jagiellonian Univ, Dept Hematol, Coll Med, Krakow, Poland
[3] Jagiellonian Univ, Chair Hematol, Coll Med, Krakow, Poland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [21] Radiobiology of radioimmunotherapy with 90Y ibritumomab tiuxetan (Zevalin)
    Hernandez, MC
    Knox, SJ
    SEMINARS IN ONCOLOGY, 2003, 30 (06) : 6 - 10
  • [22] Radioimmunotherapy (90Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study
    Pavone, Vincenzo
    Mele, Anna
    Rana, Antonio
    Del Casale, Cosimo
    Messa, Anna Rita
    Greco, Giuseppina
    Sibilla, Silvia
    De Francesco, Rosa
    Frusciante, Vincenzo
    Varraso, Antonio
    Vitolo, Umberto
    Botto, Barbara
    Milone, Giusppe
    Leotta, Salvatore
    Iacopino, Pasquale
    Console, Giuseppe
    Olivieri, Attilio
    Cimminiello, Michele
    Mettivier, Vincenzo
    Pezzullo, Luca
    Baronciani, Donatella
    Angelucci, Emanuele
    Musso, Maurizio
    Scalone, Renato
    Cascavilla, Nicola
    Scalzulli, Polito Rosario
    Capalbo, Silvana
    Loseto, Giacomo
    Quarta, Giovanni
    Musto, Pellegrino
    Caputo, Margherita
    Ostuni, Angelo
    BLOOD, 2008, 112 (11) : 418 - 418
  • [23] Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin’s lymphoma
    Gregory A. Wiseman
    Christine A. White
    Michael Stabin
    William L. Dunn
    William Erwin
    Magnus Dahlbom
    Andrew Raubitschek
    Kastytis Karvelis
    Timothy Schultheiss
    Thomas E. Witzig
    Richard Belanger
    Stewart Spies
    Daniel H. S. Silverman
    Judy R. Berlfein
    Eric Ding
    Antonio J. Grillo-López
    European Journal of Nuclear Medicine, 2000, 27 : 766 - 777
  • [24] A phase ii study of yttrium 90 (90Y) ibritumomab tiuxetan (Zevalin®) for treatment of patients with relapsed and refractory mantle cell lymphoma (MCL)
    Younes, A
    Rodriguez, M
    Pro, B
    McLaughlin, P
    Romaguera, J
    Hagemeister, F
    Wang, M
    ANNALS OF ONCOLOGY, 2005, 16 : 96 - 96
  • [25] A phase II study of yttrium 90 (90Y) ibritumomab tiuxetan (Zevalin®) for treatment of patients with relapsed and refractory mantle cell lymphoma (MCL).
    Oki, Y
    Pro, B
    Delpassand, E
    Ballaster, V
    McLaughlin, P
    Romaguera, J
    Wang, M
    Hagemeister, FB
    Younes, A
    BLOOD, 2004, 104 (11) : 720A - 720A
  • [26] Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma
    Wiseman, GA
    White, CA
    Stabin, M
    Dunn, WL
    Erwin, W
    Dahlbom, M
    Raubitschek, A
    Karvelis, K
    Schultheiss, T
    Witzig, TE
    Belanger, R
    Spies, S
    Silverman, DHS
    Berlfein, JR
    Ding, E
    Grillo-Lópezs, AJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (07) : 766 - 777
  • [27] Radioimmunotherapy with 90Y ibritumomab tiuxetan in aggressive lymphoma: evaluation of efficacy and safety in mantle cell lymphoma.
    Boni, G.
    Lorenzoni, A.
    Galimberti, S.
    Cataldi, A. G.
    Orciuolo, E.
    Cecconi, N.
    Ciuti, S.
    Petrini, M.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S148 - S148
  • [28] Radioimmunotherapy in mantle cell lymphoma
    Skarbnik, Alan P.
    Smith, Mitchell R.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2012, 25 (02) : 201 - 210
  • [29] Preparation and evaluation of 89Zr-Zevalin for monitoring of 90Y-Zevalin biodistribution with positron emission tomography
    Perk, Lars R.
    Visser, Otto J.
    Walsum, M. Stigter-van
    Vosjan, Maria J. W. D.
    Visser, Gerard W. M.
    Zijlstra, Josee M.
    Huijgens, Peter C.
    van Dongen, Guus A. M. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (11) : 1337 - 1345
  • [30] Preparation and evaluation of 89Zr-Zevalin for monitoring of 90Y-Zevalin biodistribution with positron emission tomography
    Lars R. Perk
    Otto J. Visser
    M. Stigter-van Walsum
    Maria J. W. D. Vosjan
    Gerard W. M. Visser
    Josée M. Zijlstra
    Peter C. Huijgens
    Guus A. M. S. van Dongen
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 1337 - 1345
12345